Literature DB >> 15669698

Prediction of hERG K+ blocking potency: application of structural knowledge.

A O Aptula1, M T D Cronin.   

Abstract

Modelling of QT-prolongation has been performed using data for 19 structurally diverse hERG K+ channel blocking drugs taken from literature. The modelling used hydrophobicity corrected for ionisation (log D) and various 2D and 3D physico-chemical molecular descriptors. Stepwise regression produced a two parameter, interpretable and transparent QSAR with good statistical fit, including log D and the maximum diameter of molecules (Dmax). Two strategies were applied for model validation: (i) a scrambling procedure, i.e., training the total set of 19 chemicals after randomising the hERG K+ channel blocking activity data and (ii) use of external validation sets. Validation of the models showed them to be stable and statistically significant. The effect of molecular size on QT-prolongation side effect is discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15669698     DOI: 10.1080/10629360412331297353

Source DB:  PubMed          Journal:  SAR QSAR Environ Res        ISSN: 1026-776X            Impact factor:   3.000


  7 in total

1.  Investigation of miscellaneous hERG inhibition in large diverse compound collection using automated patch-clamp assay.

Authors:  Hai-bo Yu; Bei-yan Zou; Xiao-liang Wang; Min Li
Journal:  Acta Pharmacol Sin       Date:  2016-01       Impact factor: 6.150

2.  Shape signatures: new descriptors for predicting cardiotoxicity in silico.

Authors:  Dmitriy S Chekmarev; Vladyslav Kholodovych; Konstantin V Balakin; Yan Ivanenkov; Sean Ekins; William J Welsh
Journal:  Chem Res Toxicol       Date:  2008-05-08       Impact factor: 3.739

3.  Novel Bayesian classification models for predicting compounds blocking hERG potassium channels.

Authors:  Li-li Liu; Jing Lu; Yin Lu; Ming-yue Zheng; Xiao-min Luo; Wei-liang Zhu; Hua-liang Jiang; Kai-xian Chen
Journal:  Acta Pharmacol Sin       Date:  2014-06-30       Impact factor: 6.150

4.  Creation of Novel Cores for β-Secretase (BACE-1) Inhibitors: A Multiparameter Lead Generation Strategy.

Authors:  Jenny Viklund; Karin Kolmodin; Gunnar Nordvall; Britt-Marie Swahn; Mats Svensson; Ylva Gravenfors; Fredrik Rahm
Journal:  ACS Med Chem Lett       Date:  2014-02-03       Impact factor: 4.345

5.  Potent Hepatitis C Virus NS5A Inhibitors Containing a Benzidine Core.

Authors:  Il Hak Bae; Jin Kyu Choi; Chieyeon Chough; Sun Ju Keum; Heesun Kim; Sung Key Jang; B Moon Kim
Journal:  ACS Med Chem Lett       Date:  2013-12-04       Impact factor: 4.345

Review 6.  Cellular basis of drug-induced torsades de pointes.

Authors:  D M Roden
Journal:  Br J Pharmacol       Date:  2008-06-16       Impact factor: 8.739

7.  Prediction of hERG inhibition of drug discovery compounds using biomimetic HPLC measurements.

Authors:  Chrysanthos Stergiopoulos; Fotios Tsopelas; Klara Valko
Journal:  ADMET DMPK       Date:  2021-06-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.